MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH — Clinical Trial Site

54 Registered trials

21 Currently recruiting

Organisation

MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH

Location

Hamburg, Germany

Identifier

ORG-100043080

Address

Mönckebergstraße 27, Hamburg-Altstadt, 20095, Germany

Departments

#301: Rheumatology
#40029; Rheumatology
#40029: HRF II-Hamburger Rheuma Forschungszentrum II
#40029: Rheumatology
Clinical research
Clinical Studies
Dr. Andrea Everding GmbH GbR, HRF II - Hamburger Rheuma Forschungszentrum II
Forschungszentrum II im MVZ für Rheumatologie und Autoimmunmedizin Hamburg GmbH
Hamburger Rheuma Forschungszentr um II
Hamburger Rheuma Forschungszentrum (HRF II) II
Hamburger Rheuma Forschungszentrum (HRF)
Hamburger Rheuma Forschungszentrum II
Hamburger Rheuma Forschungszentrum II - HRF II
Hamburger Rheuma Forschungszentrum II Dr. Andrea Everding GmbH GbR
Hamburger Rheuma Forschungszentrum II/ Dr. Andrea Everding GmbH GbR
Hamburger Rheuma-Forschungszentrum (HRF)
HRF
HRF II
HRF II - Hamburger Rheuma Forschungszentrum II
HRF II - Hamburger Rheuma Forschungszentrum II MVZ für Rheumatologie und Autoimmunmedizin Hamburg
HRF II – Hamburger Rheuma Forschungszentrum II
MVZ fuer Rheumatologie und Autoimmunmedizin Hamburg GmbH
MVZ fuer Rheumatologie und Autoimmunmedizin Hamburg GmbH / Dr. Andrea Everding GmbH GbR
MVZ für Rheumatologie und Autoimmunmedizin Hamburg GmbH
MVZ Rheumatologie und Autoimmunmedizin
MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH
N/A
NA
Rheumatologie & Autoimmunmedizin
Rheumatologie und Autoimmunmedizin

Clinical trials at this site (54)

Search interface

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) ( MOVE-Lp(a) ) Ended

2025-521067-13-00 Atherosclerotic Cardiovascular Disease (ASCVD) 5 2026-04-24
Trial of Sibeprenlimab in the Treatment of Sjögren’s Disease Ended

2024-516295-14-00 Treatment of Sjögren’s disease 4 2025-09-17
A Phase 2b to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With ACPA-Positive Rheumatoid Arthritis Ended

2024-515973-82-00 ACPA-Positive Rheumatoid Arthritis 4 2025-06-23
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY) Ended

2024-516609-22-00 Primary Sjögren’s Disease 5 2025-04-15
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-naïve Participants with Active Psoriatic Arthritis Ended

2023-509239-19-00 Active Psoriatic Arthritis 5 2025-04-03
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active… Ended

2024-516213-20-00 Psoriatic arthritis 5 2025-03-25
A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended

2024-511738-11-00 Psoriatic arthritis 5 2024-12-18
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome Ended

2023-503923-24-00 Sjögren’s Syndrome With Moderate-toSevere Symptom State 5 2024-07-22
A Phase 3b/4 Randomized, Double-Blind, Double-Dummy, Active Comparator-Controlled Study, Comparing the Efficacy and Safety of Upadacitinib V… Ended

2022-502578-18-00 Rheumatoid Arthritis 11 2023-11-07
Efficacy of Abatacept vs Adalimumab in Early, Autoantibody positive Rheumatoid Arthritis (RA) and who did not respond well to methotrexate. Ended

2023-506450-20-00 Rheumatoid Arthritis 5 2021-11-05
Efficacy and Safety of Deucravacitinib Compared with Placebo in Participants with Active Psoriatic Arthritis (PsA) who are Naïve to Biologic… Ended

2023-506257-37-00 Active Psoriatic Arthritis 5 2021-10-29
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Respo… Ended

2023-505477-33-00 Psoriatic Arthritis 5 2019-06-18
A Study Comparing Risankizumab to Placebo in Subjects with Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or … Ended

2023-505478-14-00 Psoriatic Arthritis 5 2019-05-09
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Rheumatoid Arthritis who are on a Stable Dose of Meth… Ended

2022-501017-31-00 Rheumatoid arthritis 5 2016-05-10
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome Ended

2023-507680-19-00 Sjögren’s Syndrome 4 2024-11-28
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to… Ended

2023-504564-42-00 Moderate to Severe Rheumatoid Arthritis 4 2024-04-08
A study to evaluate SAR441566 efficacy and safety in adults with rheumatoid arthritis Ended

2023-503910-60-00 Rheumatoid arthritis 4 2024-03-05
A Phase 2a Multicenter, Randomized, Double Blind, Parallel, Proof of concept Study Evaluating the Efficacy and Safety of Nipocalimab and Cer… Ended

2023-504045-31-00 Rheumatoid Arthritis 4 2024-02-08
A Ph2 dose-finding study (MARS-17) to evaluate the efficacy and safety of GSK3858279 in adults with knee osteoarthritis pain. Ended

2022-502799-22-00 Knee osteoarthritis pain 4 2023-11-29
A clinical trial to investigate efficacy and safety of NT 201 injections compared with placebo injections in participants aged 18 years and … Ended

2022-501461-52-00 Moderate to severe chronic peripheral neuropathic pain 4 2023-10-17
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis Ended

2022-502994-40-00 Rheumatoid Arthritis 4 2023-09-04
Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Ended

2024-512554-15-00 COVID-19 5 2023-06-21
A study to test if izokibep improves psoriatic arthritis symptoms and to see how safe izokibep is Ended

2022-501362-22-00 Psoriatic Arthritis 10 2023-04-18
A trial of prednisolone in combination with SPI-62 or placebo in participants with polymyalgia rheumatica (PMR) Ended

2024-517406-29-00 Polymyalgia rheumatica (PMR) 4 2022-07-26